ROBOTIC RADICAL PROSTATECTOMY:
WHAT TO EXPECT BEFORE AND AFTER
Robotic prostatectomy has become the dominant approach for localised prostate cancer โ combining precise nerve-sparing dissection with faster recovery than open surgery. Knowing what to expect reduces anxiety and improves outcomes.
analyticsAt a Glance
- check_circleHospital stay 1โ2 days; catheter for 7โ10 days post-operatively
- check_circleBilateral nerve-sparing preserves erectile function potential in suitable patients
- check_circleUrinary continence recovery: 80โ90% at 3 months; >95% at 12 months
- check_circleRobotic prostatectomy available at major Indian centres at 60โ70% lower cost than the USA
What Is Robotic Radical Prostatectomy?
Radical prostatectomy removes the entire prostate gland, both seminal vesicles, and typically the ampullae of the vas deferens. The robotic-assisted approach (RARP) uses the Da Vinci surgical system โ 5โ6 small ports, 3D magnification, and articulated instruments โ to perform the same oncological operation with significantly reduced trauma to surrounding structures.
Why Robotic Technique Benefits Prostatectomy
The prostate sits deep in the narrow male pelvis, adjacent to the external urethral sphincter (continence) and neurovascular bundles (erection). Robotic 3D magnification, wristed instruments, and tremor filtration enable more precise dissection at these critical interfaces than open or laparoscopic approaches โ reducing positive margin rates and improving functional recovery.
RARP vs Open Radical Prostatectomy
RARP achieves equivalent oncological outcomes to open surgery โ comparable positive surgical margin rates, biochemical recurrence-free survival, and overall survival. Functional advantages include reduced blood loss (transfusion rare), shorter hospital stay (1โ2 vs 3โ5 days), shorter catheter duration, and faster return to continence in high-volume robotic series.
Before, During, and After: The Complete Patient Timeline
Understanding every phase โ from pre-operative preparation to PSA follow-up โ removes uncertainty and helps patients make active decisions about their recovery.
- 1
Pre-Operative Assessment (2โ4 Weeks Before)
Anaesthetic assessment, blood tests, ECG, and cross-match. Prostate MRI reviewed to plan nerve-sparing approach. Pelvic floor physiotherapy referral โ starting pre-operative pelvic floor exercises significantly improves post-operative continence recovery. Bowel preparation is not routinely required. Aspirin and anticoagulants stopped per anaesthetic guidance.
- 2
The Operation (2.5โ3.5 Hours)
General anaesthesia; Trendelenburg position (head-down). Six ports placed in lower abdomen. Prostate, seminal vesicles, and vas deferens dissected and removed. Nerve-sparing preserves the neurovascular bundles lateral to the prostate โ grade of nerve sparing (bilateral/unilateral/non-nerve-sparing) communicated to patient. Urethrovesical anastomosis re-joins urethra to bladder over a urinary catheter.
- 3
Hospital Stay (Day 1โ2)
Urinary catheter drains the bladder during anastomosis healing. Urethral catheter typically remains for 7โ10 days. Drain removed day 1โ2 if output is minimal. Most patients are mobilised on the day of surgery; discharged after 1โ2 days. Mild shoulder tip pain from residual COโ resolves within 24โ48 hours.
- 4
Catheter Removal (Day 7โ10)
The urethral catheter is removed at an outpatient visit at day 7โ10 after a cystogram confirming anastomotic healing (or at day 7 without cystogram at many experienced centres). Most patients experience some urinary leakage immediately after catheter removal โ this is normal and expected. Pelvic floor exercises should be performed diligently during this period.
- 5
Continence Recovery (Weeks 4โ12)
Continence recovery is gradual. At 4 weeks: 40โ60% continent. At 3 months: 80โ90% continent (defined as 0โ1 pad/day). At 12 months: >95% continent. Factors affecting recovery: age, pre-operative continence, nerve-sparing grade, anastomosis quality, and pelvic floor exercise compliance. Pelvic floor physiotherapy significantly accelerates recovery.
- 6
PSA Monitoring and Pathology Review
First PSA at 6 weeks post-operatively โ should be undetectable (<0.1 ng/mL). Subsequent PSAs at 3, 6, 12 months then annually. Pathology report reviewed for final Gleason grade, margin status (positive surgical margin requires risk-stratified surveillance or adjuvant radiotherapy discussion), pT stage, and nodal status if dissection performed.
Nerve-Sparing Prostatectomy: Balancing Cancer Control and Function
The neurovascular bundles running lateral to the prostate mediate erection. Nerve-sparing preserves these structures โ but is only appropriate when oncological safety is not compromised.
Bilateral Nerve-Sparing
- Indicated for low/intermediate risk, organ-confined diseaseNo MRI evidence of extraprostatic extension or neurovascular bundle involvement; PSA <10 ng/mL, Gleason โค3+4
- Best erectile function recovery potentialBilateral nerve-sparing: 50โ70% of patients regain erections adequate for intercourse by 18 months (age-dependent)
- No oncological compromise in appropriately selected patientsRARP margin rates equivalent between nerve-sparing and non-nerve-sparing in low-risk disease at experienced centres
Non-Nerve-Sparing (Wide Excision)
- Required for high-risk or extracapsular diseaseMRI showing neurovascular bundle involvement, Gleason โฅ4+3, PSA >20, palpable nodule at NVB โ wide excision is oncologically mandatory
- Unilateral nerve-sparing (one side wide excision)Asymmetric risk โ one nerve bundle excised on the higher-risk side while the contralateral is preserved
- Partial nerve-sparingIntrafascial or interfascial dissection on one or both sides โ preserves more nerve tissue in low-volume intermediate-risk disease
Functional Outcomes After Robotic Prostatectomy
Setting realistic expectations about continence and erectile function recovery after RARP โ based on published prospective series data.
| Outcome | 3 Months | 6 Months | 12 Months | Key Predictors |
|---|---|---|---|---|
| Urinary continence (0โ1 pad/day) | 70โ80% | 85โ92% | 90โ97% | Age, pre-op continence, pelvic floor exercises, anastomosis quality |
| Erectile function (bilateral NS, age <65) | 20โ30% | 40โ55% | 55โ70% | Age, pre-op erectile function, bilateral vs unilateral NS, PDE5i use |
| Erectile function (bilateral NS, age โฅ65) | 10โ20% | 25โ35% | 35โ50% | Significantly age-dependent โ older patients recover more slowly and incompletely |
| Biochemical recurrence-free survival (pT2 R0) | โ | โ | 94โ97% at 5 years | Gleason grade, pT stage, margin status, PSA kinetics |
| Positive surgical margin rate | โ | โ | 10โ18% overall; 5โ10% pT2 | Surgeon volume, nerve-sparing approach, tumour location |
Robotic Prostatectomy: Key Outcome Benchmarks
- >95%Continence at 12 Months (High-Volume Centres)Defined as 0โ1 safety pad per day; most patients continent by 6 months
- 55โ70%Erectile Function Recovery โ Bilateral NS, Age <65Erections adequate for intercourse at 12โ18 months after bilateral nerve-sparing RARP
- <1%Blood Transfusion Rate (RARP)vs 5โ15% with open radical prostatectomy โ major practical advantage
- 6 weeksTime to First Post-Operative PSAUndetectable PSA (<0.1 ng/mL) confirms complete resection; the first oncological milestone
Related Surgical Oncology Resources
More guides on cancer surgery decisions and procedures.
Frequently Asked Questions
Robotic Radical Prostatectomy
How soon can I return to work after robotic prostatectomy?
Most patients return to desk work or sedentary jobs within 2โ3 weeks. Physical work or roles requiring heavy lifting should be avoided for 4โ6 weeks until the port sites and internal recovery are complete. Driving is typically restricted while the urinary catheter is in situ and for 2 weeks after removal, or as guided by your surgeon.
What should I do if my PSA is not undetectable after prostatectomy?
A detectable PSA after radical prostatectomy (>0.2 ng/mL on two consecutive measurements) is defined as biochemical recurrence. The first step is to determine whether this represents local recurrence (prostate bed), regional nodal recurrence, or distant metastasis โ typically assessed with PSMA PET-CT. Management depends on PSA kinetics (doubling time), pathological stage, and site of recurrence. Salvage radiotherapy to the prostate bed is the most common intervention for early biochemical recurrence. CancerFax can arrange a PSA review and PSMA staging assessment for patients with post-operative PSA concerns.
Is robotic prostatectomy available in India and what does it cost?
Yes. Da Vinci robotic prostatectomy is available at Apollo Hospitals, Fortis, Manipal, and Medanta, among other leading Indian centres. The total cost of robotic radical prostatectomy in India โ including pre-operative assessment, surgery, hospital stay, and pathology โ is typically $4,500โ$8,000, compared to $15,000โ$35,000 in the USA. Surgeons at major Indian centres have trained at international robotic programmes and perform high-volume robotic prostatectomy series. CancerFax can identify the most appropriate surgeon and centre based on your Gleason grade, PSA, and MRI findings.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination โ travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Considering Robotic Prostatectomy? Get Expert Guidance.
Upload your PSA history, biopsy, and MRI. CancerFax will assess your surgical candidacy and connect you with experienced robotic prostatectomy surgeons in India.
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified oncologist before making treatment decisions.